Sitagliptin Added-on to Insulin Study (0431-051)
- Status
- COMPLETED
- Phase
- PHASE3
Clinical Trials Related to Type 2 Diabetes Mellitus
Related studies linked through entity extraction aliases.
Acetylcarnitine and Insulin Sensitivity
- Status
- COMPLETED
- Phase
- PHASE2
Study Of Denagliptin In Subjects With Type 2 Diabetes Mellitus (T2DM)
- Status
- WITHDRAWN
- Phase
- PHASE2/PHASE3
A Study to Assess the Effect on Glucose Control and Safety and Tolerability of LY2148568 In Japanese Patients With Type 2 Diabetes
- Status
- COMPLETED
- Phase
- PHASE2
Safety and Efficacy of Exenatide as Monotherapy
- Status
- COMPLETED
- Phase
- PHASE3
Double-Blind Study of Miglitol in Japanese With type2 Diabetes
- Status
- COMPLETED
- Phase
- PHASE3
Safety and Tolerability Study of Cycloset in Treatment of Type 2 Diabetes
- Status
- COMPLETED
- Phase
- PHASE3
Drug Interactions From Simultaneous Administration Of Metformin And GSK189075 To Subjects With Type 2 Diabetes
- Status
- COMPLETED
- Phase
- PHASE1
Effect on Weight Loss of Exenatide Versus Placebo
- Status
- COMPLETED
- Phase
- PHASE3
The HOME Trial: Hyperinsulinaemia: the Outcome of Its Metabolic Effects, a Randomized Controlled Trial
- Status
- COMPLETED
- Phase
- PHASE3
Metabolic Effects of Treatment in Patients With Recently Diagnosed Type 2 Diabetes
- Status
- COMPLETED
- Phase
- PHASE4
MK0431 (Sitagliptin) Pioglitazone Add-on Study for Patients With Type 2 Diabetes Mellitus (0431-055)(COMPLETED)
- Status
- COMPLETED
- Phase
- PHASE3
MK-0431 Early Phase II Double-blind Study - Type 2 Diabetes Mellitus (0431-043)
- Status
- COMPLETED
- Phase
- PHASE2
Rosiglitazone-Metformin Combination Versus Metformin-Sulfonylurea Combination On Beta-Cell Function In Type 2 Diabetes
- Status
- COMPLETED
- Phase
- PHASE4
Examination of Dermatologic Effects From Subcutaneous Injections of ISIS 113715
- Status
- COMPLETED
- Phase
- PHASE1
Controlled Study of MK-0431/ONO-5435 in Patients With Type 2 Diabetes Mellitus
- Status
- COMPLETED
- Phase
- PHASE3
Controlled Study of MK-0431/ONO-5435 in Patients With Type 2 Diabetes Mellitus
- Status
- COMPLETED
- Phase
- PHASE3
Controlled Study of MK-0431/ONO-5435 in Patients With Type 2 Diabetes Mellitus
- Status
- COMPLETED
- Phase
- PHASE3
Olmesartan Medoxomil and Diabetic Nephropathy
- Status
- COMPLETED
- Phase
- PHASE3
Dose-Ranging Study Evaluating AVE2268 in Patients With Type 2 Diabetes Not Adequately Controlled by a Metformin Treatment
- Status
- COMPLETED
- Phase
- PHASE2